Nothing said here yet.
to join the conversation.
| Sitaram SiddharthChief Accounting Officer | Sell | 2,613 | $80.2K | Wed, Oct 14 |
| Wampler Kira SchererDirector | Sell | 2,000 | $57.8K | Thu, Oct 1 |
| Yang Watkin Phoebe L.Director | Sell | 1,290 | $34.5K | Wed, Sep 30 |
| Sitaram SiddharthChief Accounting Officer | Sell | 2,077 | $54.0K | Tue, Sep 15 |
| Wampler Kira SchererDirector | Sell | 2,000 | $52.7K | Tue, Sep 1 |
| Wampler Kira SchererDirector | Sell | 2,000 | $49.9K | Tue, Aug 25 |
| Sitaram SiddharthChief Accounting Officer | Sell | 1,770 | $44.1K | Thu, Aug 13 |
Tempus AI or Doximity: Which medical information systems stock offers better value? Compare growth prospects, AI expansion, earnings estimates and valuation.
Doximity’s updated analyst work now anchors around a fair value estimate of US$30.94, up from US$29.67, which fine tunes where some investors may see the stock’s long term potential.
Shares of medical professional network Doximity (NYSE:DOCS) jumped 7.3% in the afternoon session after the company announced a partnership with Wolters Kluwer Health to integrate UpToDate clinical content into its Doximity Ask platform.
The health AI companies are putting to bed a legal dispute involving dueling lawsuits, claims of corporate espionage and allegations of harassment.
Doximity (DOCS) closed the most recent trading day at $30.71, moving 2.51% from the previous trading session.
DOCS extends its 13-year partnership with U.S. News, strengthening its role in physician searches, appointment booking and hospital rankings.
Doximity helps to power U.S. News' Doctor Finder, Patient Connect appointment booking tools used by over 65 million Americans annually to find and schedule care SAN FRANCISCO and WASHINGTON, Oct.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Doximity (NYSE:DOCS) and its peers.